Application YC di Adventris Pharmaceuticals

Winter 2023Active

Adventris Pharmaceuticals ha partecipato a Y Combinator nel batch Winter 2023 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Winter 2023
Settore: HealthcareDrug Discovery and Delivery
Dimensione team: 7
Stato: Active
Lanciata: 2023

Founder

Jen HerbachFounder
William CollisFounder
Mark YarchoanFounder

Cosa fa Adventris Pharmaceuticals

Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually - preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at

Application YC di Adventris Pharmaceuticals, ricostruita

Domanda per Y Combinator

Adventris Pharmaceuticals, batch Winter 2023. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Adventris Pharmaceuticals

Describe what your company does in 50 characters or less.

Adventris makes cancer vaccines

What is your company going to make? Please describe your product and what it does or will do.

We make cancer vaccines designed to target oncogenes that typically evade immune detection. Our first product is an "off-the-shelf" vaccine targeting KRAS, which is the most common cancer oncogene. Our platform aims to enable vaccines that could prevent many cancers before they develop.

Where do you live now, and where would the company be based after YC?

We live in Baltimore, MD and plan to keep the company based here after YC.

Explain your decision regarding location.

Baltimore has strong biotech resources and is our home. Staying here keeps us close to our team and research partners.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di Adventris Pharmaceuticals?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di Adventris Pharmaceuticals (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come Adventris Pharmaceuticals si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva Adventris Pharmaceuticals?

Adventris Pharmaceuticals apparteneva al batch Winter 2023 di Y Combinator.

Chi ha fondato Adventris Pharmaceuticals?

Adventris Pharmaceuticals è stato fondato da Jen Herbach, William Collis, Mark Yarchoan.

Cosa fa Adventris Pharmaceuticals?

Adventris makes cancer vaccines

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di Adventris Pharmaceuticals, e di ogni altro batch YC, è in YC Insights.